| pubmed-article:2557331 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2557331 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:2557331 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:2557331 | lifeskim:mentions | umls-concept:C1123019 | lld:lifeskim |
| pubmed-article:2557331 | lifeskim:mentions | umls-concept:C0040690 | lld:lifeskim |
| pubmed-article:2557331 | lifeskim:mentions | umls-concept:C0056371 | lld:lifeskim |
| pubmed-article:2557331 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:2557331 | pubmed:issue | 36 | lld:pubmed |
| pubmed-article:2557331 | pubmed:dateCreated | 1990-2-1 | lld:pubmed |
| pubmed-article:2557331 | pubmed:abstractText | Transforming growth factor beta (TGF beta) is a potent inhibitor of adrenocortical cell differentiated functions, whereas corticotropin (ACTH) is the main physiological hormone which acts positively on these functions. We have studied the effects of both TGF beta and ACTH on ovine adrenocortical cell ACTH receptors. Ovine adrenocortical cells contained specific high affinity (Kd = 2.7 +/- 1.6 x 10(-10) M) and low capacity (1190 +/- 120 sites/cell) ACTH receptors. Pretreatment of cells with TGF beta resulted in a time- and dose-dependent (ED50 = 50 pg/ml) decrease of 125I-ACTH1-39 binding. The observed decrease in ACTH binding was due to a 2-3-fold decrease in the number of binding sites without modification of the binding affinity. On the contrary, pretreatment of cells with ACTH caused a 4-4.5-fold increase in the number of ACTH binding sites without an effect on the Kd. When cells were pretreated with both ACTH and TGF beta, TGF beta blocked completely the positive trophic effect of ACTH on its own receptors. The variations in ACTH receptor number were associated with parallel changes on acute ACTH-induced cyclic AMP production. Thus, the effects of TGF beta on ACTH receptor content are likely another important negative action of this peptide on adrenocortical cell differentiation. Moreover, these results suggest that regulation of ACTH receptor number may be one mechanism by which hormones and growth factors control adrenocortical differentiation. | lld:pubmed |
| pubmed-article:2557331 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2557331 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557331 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2557331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557331 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2557331 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2557331 | pubmed:issn | 0021-9258 | lld:pubmed |
| pubmed-article:2557331 | pubmed:author | pubmed-author:SaezJ MJM | lld:pubmed |
| pubmed-article:2557331 | pubmed:author | pubmed-author:ViardII | lld:pubmed |
| pubmed-article:2557331 | pubmed:author | pubmed-author:RaineyW EWE | lld:pubmed |
| pubmed-article:2557331 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2557331 | pubmed:day | 25 | lld:pubmed |
| pubmed-article:2557331 | pubmed:volume | 264 | lld:pubmed |
| pubmed-article:2557331 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2557331 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2557331 | pubmed:pagination | 21474-7 | lld:pubmed |
| pubmed-article:2557331 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:meshHeading | pubmed-meshheading:2557331-... | lld:pubmed |
| pubmed-article:2557331 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2557331 | pubmed:articleTitle | Transforming growth factor beta treatment decreases ACTH receptors on ovine adrenocortical cells. | lld:pubmed |
| pubmed-article:2557331 | pubmed:affiliation | Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235. | lld:pubmed |
| pubmed-article:2557331 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2557331 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2557331 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2557331 | lld:pubmed |
